Effects on diffusing capacity and ventilation–perfusion relationships of budesonide inhalations for 2 months in chronic obstructive pulmonary disease (COPD)
Authors:
- 1 August 2001
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 95 (8) , 676-684
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Changes in carbon monoxide transfer over 22 years in middle-aged menRespiratory Medicine, 2000
- Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue SmokingNew England Journal of Medicine, 1999
- Immunopathology of the Small-Airway Submucosa in Smokers with and without Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary diseaseThorax, 1998
- Effects of Long-term Treatment With Corticosteroids in COPDChest, 1996
- Slowing the Deterioration of Asthma and Chronic Obstructive Pulmonary Disease Observed during Bronchodilator Therapy by Adding Inhaled Corticosteroids: A 4-Year Prospective StudyAnnals of Internal Medicine, 1993
- Influence of smoking habits on change in carbon monoxide transfer factor over 10 years in middle aged men.Thorax, 1993
- A Comparison of Bronchodilator Therapy with or without Inhaled Corticosteroid Therapy for Obstructive Airways DiseaseNew England Journal of Medicine, 1992
- Alveolar Attachments in Emphysema of Human LungsAmerican Review of Respiratory Disease, 1991
- Continuous Distributions of Ventilation-Perfusion Ratios in Normal Subjects Breathing Air and 100% O2Journal of Clinical Investigation, 1974